These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 14578916)

  • 21. Reaching the therapeutic goal in hypertension: results from the Canadian valsartan observational study. (Diovantage 4).
    Tardif JC; Curnew GP; Leclerc JM; Rehel B
    Can J Clin Pharmacol; 2008; 15(2):e177-87. PubMed ID: 18515919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood pressure control in treated hypertensive patients: clinical performance of general practitioners.
    Frijling BD; Spies TH; Lobo CM; Hulscher ME; van Drenth BB; Braspenning JC; Prins A; van der Wouden JC; Grol RP
    Br J Gen Pract; 2001 Jan; 51(462):9-14. PubMed ID: 11271892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study.
    Kjeldsen SE; Jamerson KA; Bakris GL; Pitt B; Dahlöf B; Velazquez EJ; Gupte J; Staikos L; Hua TA; Shi V; Hester A; Tuomilehto J; Ostergren J; Ibsen H; Weber M;
    Blood Press; 2008; 17(1):7-17. PubMed ID: 18568687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study.
    Holzgreve H; Risler T; Trenkwalder P
    Curr Med Res Opin; 2006 Sep; 22(9):1849-58. PubMed ID: 16968588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).
    McLean DL; McAlister FA; Johnson JA; King KM; Makowsky MJ; Jones CA; Tsuyuki RT;
    Arch Intern Med; 2008 Nov; 168(21):2355-61. PubMed ID: 19029501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide.
    Guerrero P; Fuchs FD; Moreira LM; Martins VM; Bertoluci C; Fuchs SC; Gus M
    Clin Exp Hypertens; 2008 Oct; 30(7):553-64. PubMed ID: 18855259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reasons for not intensifying antihypertensive treatment to diabetes in some regions of China].
    Guo QH; Pan CY; Qi WH; Lin SY;
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):240-4. PubMed ID: 18361834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The medication Adherence and Blood Pressure Control (ABC) trial: a multi-site randomized controlled trial in a hypertensive, multi-cultural, economically disadvantaged population.
    Gerin W; Tobin JN; Schwartz JE; Chaplin W; Rieckmann N; Davidson KW; Goyal TM; Jhalani J; Cassells A; Feliz K; Khalida C; Diaz-Gloster M; Ogedegbe G
    Contemp Clin Trials; 2007 Jul; 28(4):459-71. PubMed ID: 17287150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertension control: how well are we doing?
    Borzecki AM; Wong AT; Hickey EC; Ash AS; Berlowitz DR
    Arch Intern Med; 2003 Dec 8-22; 163(22):2705-11. PubMed ID: 14662624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004.
    Gu Q; Burt VL; Paulose-Ram R; Dillon CF
    Am J Hypertens; 2008 Jul; 21(7):789-98. PubMed ID: 18451806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-monitoring of blood pressure promotes achievement of blood pressure target in primary health care.
    Halme L; Vesalainen R; Kaaja M; Kantola I;
    Am J Hypertens; 2005 Nov; 18(11):1415-20. PubMed ID: 16280273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [District program to improve the cardiovascular risk of resistant hypertensive patients in general medicine].
    Denolle T; Eon Y; Le Néel H; Seignard H; Battini J
    Arch Mal Coeur Vaiss; 2005; 98(7-8):761-6. PubMed ID: 16220744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood pressure control among Indians with hypertension: the I-Target survey.
    Hathial M
    J Indian Med Assoc; 2007 Jul; 105(7):401-2, 404, 410. PubMed ID: 18178998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.
    Peters-Klimm F; Müller-Tasch T; Remppis A; Szecsenyi J; Schellberg D
    J Eval Clin Pract; 2008 Oct; 14(5):823-9. PubMed ID: 19018915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized study of traditional versus aggressive systolic blood pressure control (Cardio-Sis): rationale, design and characteristics of the study population.
    Cardio-Sis Study Group
    J Hum Hypertens; 2008 Apr; 22(4):243-51. PubMed ID: 18046432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood pressure responder rates versus goal rates: which metric matters?
    Basile J
    Ther Adv Cardiovasc Dis; 2009 Apr; 3(2):157-74. PubMed ID: 19299428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.